Concepedia

Shengye Liu

SL

11

Publications

304

Citations

10

H-Index

2016

Active since

Affiliations

China Medical University(Current)

Shengye Liu is an author at China Medical University specializing in medicine, cell biology, and molecular signaling.

ORCID

Top concepts

Publications per year

2016–2021

11

Publications

11

TRIM29 Overexpression Promotes Proliferation and Survival of Bladder Cancer Cells through NF-κB Signaling

Shutao Tan, Shengye Liu, Bin Wu · Cancer Research and Treatment · 2016 · 57 citations · Full text

Gastrodin protects MC3T3-E1 osteoblasts from dexamethasone-induced cellular dysfunction and promotes bone formation via induction of the NRF2 signaling pathway

Shengye Liu, Tao Fang, Liyu Yang et al. · International Journal of Molecular Medicine · 2018 · 49 citations · Full text

, , +25

Epigallocatechin-3-Gallate Ameliorates Glucocorticoid-Induced Osteoporosis of Rats in Vivo and in Vitro

Shengye Liu, Liyu Yang, Shuai Mu et al. · Frontiers in Pharmacology · 2018 · 38 citations · Full text

Paeoniflorin Attenuates Dexamethasone-Induced Apoptosis of Osteoblast Cells and Promotes Bone Formation via Regulating AKT/mTOR/Autophagy Signaling Pathway

Liyu Yang, Shengye Liu, Shuai Mu et al. · Evidence-based Complementary and Alternative Medicine · 2021 · 31 citations · Full text

MicroRNA‑93 regulates angiogenesis in peripheral arterial disease by targeting CDKN1A

Xiaojun Shu, Youjun Mao, Zhengfei Li et al. · Molecular Medicine Reports · 2019 · 25 citations · Full text

, , +18

Rows per page

1–5 of 11